NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
PHARMALEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMALEX
ST13
US500000098015957Class
35, 42, 44, 45
Filing
98015957
Registration
7675015
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/04/2025
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
05/26/2023
Registration date
02/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
27
Owner location
Friedrichsdorf, DE
Examiner
WU, KRISTEN ZAHNOW
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PharmaLex GmbH
Representatives
Anita B. Polott Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising and marketing; management of business for others; business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business development services and advice in the field of drug distribution in retail and wholesale stores for advertising purposes; providing outsourced office functions services for drug approvalmanufacturingdistributionsupply chain security and safety monitoring; assistance and consultancy in the field of distributing medicines for advertising purposes via retail stores and wholesale stores; business consultancy services in the fields of controlling and managing business information and implementing and managing databases; regulatory submission managementassisting others in preparing and filing applicationsdocumentsreports and records for new drugs required for drug approval by governmental regulatory authorities; advisory services in the field of regulatory submission management to assist companies with applications for pharmaceuticalsbiopharmaceuticalsmedical devices; business advice and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with applications for drug approval; regulatory submission managementassisting others in preparing and filing marketing authorization applications with governmental regulatory bodies following approval of new drugs; consultancy relating to conducting quality assurance for manufacturing for pharmaceutical companies
Class 42
Scientific and technological servicesresearch and design in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; scientificmedical and pharmaceutical research and development services; industrial analysis and research services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientificmedicalbiotechnologicalpharmaceutical research services; biological research and analysis services for scientific and technological purposes; technological research services relating to pharmaceuticalsbiopharmaceuticalsmedical devices; biological research; clinical research in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; providing medical research and scientific research information; provision of scientific information in the nature of scientific surveys; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticalsvaccinesmedicinebiologicsbiotherapeuticsbiosimilarstherapeutics; computer software development of a web application for entering and evaluating informative texts for pharmaceuticals and medical productsin particular instructions for usepackage insertsspecialist information and for the provision of various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; testinginspection or research of pharmaceuticals and medicines; designengineeringresearchdevelopment and testing services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research in the field of gene therapy; consultancy relating to quality management servicesquality assurance and quality control in the field of pharmaceuticalspharmaceutical manufacturingmedical devicesbiopharmaceuticals; research services relating to scientific work; preparation of scientific research analyses and evaluations relating to pharmaceuticalsmedical devicesbiopharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to scientific laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; information technology consultancy services relating to computer software design for the pharmaceutical and healthcare industries; scientific evaluation of the drugs of others to determine drug efficacy; research and development services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design for others; analysis and evaluation of product development for others; quality control testing for others; materials testing and evaluation; product safety testing; quality control and evaluation of goods of others to determine conformity with certification standards; quality testing of products for certification purposes; consulting and advice on drug safety and monitoring for product research and development purposes; consultancy services for others in the field of designplanningimplementation and project management of clinical trialsscientific pharmacovigilance researchpharmaceutical and biotechnology product development; consultancy services in the fields of biotechnologypharmaceutical research and developmentlaboratory testing of materials and pharmacogenetics; providing online nondownloadable software for collecting data related to clinical trials; providing online non-downloadable automation software for collecting data related to clinical trials; provision of pharmaceutical information regarding pharmaceutical research and development; consultancy and information services provided via the Internet relating to the research and development of pharmaceutical products; pharmaceutical drug development services in the field of drug safety
Class 44
Medical and veterinary services; advice in the field of preparation of prescriptions in pharmacies; providing medical advice regarding the appropriate medical information that should appear on labels of pharmaceutical products and biopharmaceutical products; providing information relating to the preparation and dispensing of medications; provision of information in the field of medicine; consultancy and information services provided via the Internet relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the dispensing of biopharmaceutical products; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations relating to the treatment of persons; medical analysis services relating to the treatment of persons; medical services; medical screening; medical diagnostic monitoringtestinginspection and analysis services relating to the diagnosis and treatment of illnesses; medical and medical diagnostic services and medical advice in the field of drug safety for the diagnosis and treatment of persons; providing information in the field of pharmacovigilance and adverse event reporting for the diagnosis and treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of persons
Class 45
Regulatory compliance auditing; regulatory compliance consulting in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; consultancy services in the fields of regulatory compliance and oversight in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; advisory services relating to regulatory compliance auditing; regulatory compliance consultancy in the field of prescription drug sampling
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/17/2024
PUBO
PUBLISHED FOR OPPOSITION
12/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2024
ALIE
ASSIGNED TO LIE
11/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/20/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2024
GNRT
NON-FINAL ACTION E-MAILED
02/21/2024
CNRT
NON-FINAL ACTION WRITTEN
02/21/2024
DOCK
ASSIGNED TO EXAMINER
02/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2023
NWAP
NEW APPLICATION ENTERED
05/30/2023
Continuous trademark protection
Get notified about every new filing that threatens PHARMALEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.